A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications

Dry powder inhaler (DPI) is an attractive dosage form for local and systemic pulmonary drug delivery. However, designing DPIs with adequate physicochemical properties is challenging. The development of novel pulmonary drug delivery systems requires the selection of suitable particle engineering techniques, carriers, and excipients. In addition, optimization of physico-chemical properties of such systems is critical for their efficient delivery and drug release. This review highlights the recent advances in the field of inhalable dry powder formulations with a special emphasis on the current particle engineering techniques, challenges in the development of novel pul-monary drug delivery systems, selection of a suitable carrier and excipients, and the evaluation of factors impacting aerosolization. Lastly, the review also discusses the current and emerging applications of DPIs for local and systemic drug delivery.

Automated summary

Dry powder inhalers (DPIs) are attractive drug delivery systems for the lungs, but designing them with suitable physicochemical properties is challenging. The development of novel DPIs requires the selection of appropriate particle engineering techniques, carriers, and excipients. Optimizing the physicochemical properties of these systems is crucial for efficient drug delivery. This review focuses on recent advances in inhalable dry powder formulations, including current particle engineering techniques, challenges in DPI development, carrier and excipient selection, and factors influencing aerosolization. It also discusses the current and emerging applications of DPIs for local and systemic drug delivery.